+33(0)1 42 54 60 64 | contact@welcomeurope.com

Login

Digital Europe – Testing and Experimentation Facility for Health – 2022

Digital Europe - Testing and Experimentation Facility for Health - 2022 Funds for: fostering trust and acceptance by the user community and boost the roll-out of European AI, data and robotics solutions from the lab to the market, through its validation process, increasing the maturity of the tested solutions.

2022-05-17
30 million euro
Close

Appeal framework

Institution European Commission
Sectors Cooperation & Development Education & Training Health
Beneficiaries All beneficiaries Association & NGO
Regions Developing countries, European Economic Area, European Union
Details

Associated countries and countries which are in ongoing negotiations for an association agreement and where the agreement enters into force before grant signature are equally eligible to the grant

For more information: Click here

Content reserved for subscribers

Register for free to access the content

Free access to all information

Priorities and funded actions

Objectives

  • To foster trust and acceptance by the user community and boost the roll-out of European AI, data and robotics solutions from the lab to the market, through its validation process, increasing the maturity of the tested solutions
  • To accelerate testing by creating common, accessible infrastructures and services, which combine the necessary technical, administrative, medical and ethical procedures and certifications, as appropriate
  • To increase the effectiveness, resilience and sustainability of European health and care systems and reduce healthcare delivery inequalities in Europe, while ensuring compliance with relevant legal, ethical, quality and interoperability standards and requirements

Priorities

  • Priority 1: to build synergies with existing and future European initiatives related to the Digital Transformation of Health and Care, the European Health Data Space, AI Regulation, Data Governance Act, Europe’s Beating Cancer Plan
  • Priority 2: To allow for large-scale in-silico, in vitro, ex-vivo and in vivo testing, when relevant

Among financed actions 

  • Prevention, diagnostics, treatments and rehabilitation of infectious and non-communicable diseases, including cancer, dementia, paediatrics and promotion of healthy lifestyles
  • Monitoring the progress of long‑term conditions in function of treatment (e.g.diabetes mellitus, neurodegenerative diseases etc.)
  • Support to doctors’ decision-making, including personalised, predictive and age- and gender-sensitive treatments
  • Detection of tumours from imaging

Additional information 

  • This call for proposals is an open call for proposals
  • Initial duration of the action: between 48 and 60 months

Eligibility

  • Be legal entities (public or private bodies)
  • Be established in one of the eligible countries
Financement
  • Total budget of the call: 156 million euro
  • Total budget of the topic: 30 million euro
  • Amount of the grant: 30 million euro
  • Co-financing rate: up to 50%

Test your eligibility

Similar news

14 February 2022

€1.3 billion for HERA first work plan – a step towards the European Health Union

Lire l'aticle

21 February 2022

16-20 May 2022: European Public Health Week

Lire l'aticle